When:
September 10, 2015 @ 2:00 pm – 3:15 pm America/Chicago Timezone
2015-09-10T14:00:00-05:00
2015-09-10T15:15:00-05:00
Contact:
Lori Hintz, RN
(605) 354-3187

medical team meeting

Start WebEx Playback

Presentation Handouts

Dr. Lisa O’Hara’s PowerPoint Presentation

Comprehensive Therapy Specialists Behavioral Health Evaluation

Overview

CMS has issued a new challenge to reduce antipsychotic utilization in nursing homes by 25 percent by the end of 2015 and 30 percent by the end of 2016.  While most nursing home facilities have successfully met or exceeded the original goal of reducing utilization by 15 percent, several facilities have yet to meet this goal and are at risk of not achieving the new goals.

This session will aim to provide participants with the necessary information to understand the intent of the federal regulations and antipsychotic reduction initiative as well as provide the necessary tools to develop or improve upon current behavioral health programs within nursing home facilities.

 

Objectives

The participant should be able to:

  1. Discuss F309 (Quality of Care) and F329 (Unnecessary Medications) of the State Operations Manual as they relate to the use of antipsychotic medications while associating their intent with improved patient centered care.
  2. Assess different educational materials currently available which may add benefits to newly starting or improving upon existing behavioral management meetings.
  3. Compare and contrast multiple pharmacological therapies for the treatment of Behavioral and/or Psychological Symptoms of Dementia (BPSD).
  4. Analyze your current behavioral program and consider strategies to improve upon weak areas or further strengthen strong areas to further reduce the use of psychotropic therapy to treat BPSD.

Presenter

Dr. Lisa O’Hara is co-owner of Comprehensive Therapy Specialists, LLC, an independent consulting provider that works with organizations within the senior care community to provide comprehensive medication therapy reviews, consultations, and education; expanding the role of the pharmacists into the clinical setting.  For almost a decade, Dr. O’Hara and her team have been forging the way on antipsychotic medication reductions, receiving nationwide recognition and significant achievements.  As a Certified Geriatric Pharmacist, Dr. O’Hara is also using her unique knowledge and skill set to educate the next generation of senior care pharmacists acting as a preceptor of students from Butler and Purdue University’s School of Pharmacy.

In 2013, Dr. O’Hara was a Patient Care Provider of the Year finalist for her work with the Quality Improvement Organization (QIO) Drug Safety Project, improving healthcare outcomes through clinical pharmacy interventions.  Dr. O’Hara has served on numerous boards and committees, including the Indiana Pharmacist Alliance and the American Society of Consultant Pharmacists and is a nationally recognized speaker on multiple pharmacy-related topics.  Her contributions include numerous pieces and publications focused on geriatric/long-term care areas, such as: Psychotropic Medication Reduction, Chronic Obstructive Pulmonary Disease, Diabetes Mellitus, Heart Failure, Osteoporosis, Stroke Prevention and Unnecessary Medication Use.